Strategic Corporate Finance Briefing: Term Sheets vs. iSAFE Notes in Early-Stage Venture Architectures
A comparative analysis of traditional Term Sheets and iSAFE notes for early-stage Indian ventures — covering valuation mechanics, governance rights, secretarial overhead, and founder autonomy.
Introduction
For corporate legal advisors, practicing company secretaries, and financial strategists guiding early-stage enterprises, selecting the appropriate investment instrument is a foundational corporate governance decision. The choice directly impacts a company's capital structure, compliance overhead, and founder control. Traditional priced equity funding begins with a Term Sheet, which outlines the commercial and structural agreements of an investment round. Conversely, the iSAFE (India Simple Agreement for Future Equity) note acts as a pre-equity deferred convertible instrument, adapted from the Silicon Valley SAFE model to comply with Indian corporate law.
(Pre-Seed / Seed Stage) → (Institutional Series A)
1. Definitional and Structural Deconstruction
The Traditional Term Sheet Architecture
A Term Sheet is an expression of intent that acts as the blueprint for formal transaction documents—the Share Subscription Agreement (SSA) and Shareholder Agreement (SHA). It explicitly details valuation, dividend rights, and corporate governance mechanics.
- Valuation Fixation: Locks in the precise Pre-Money and Post-Money Valuation.
- Class of Security: Involves the immediate issue of Compulsorily Convertible Preference Shares (CCPS) or Equity Shares.
- Governance Rights: Grants immediate board seats, information rights, and veto/affirmative voting privileges.
The iSAFE Note Architecture
The iSAFE note is a synthetic contractual instrument structured to comply with the Companies Act, 2013, typically issued as a special class of unpriced CCPS. It is designed to minimize early-stage legal friction.
- Valuation Deferral: Avoids immediate valuation disputes by using a Valuation Cap and/or a Discount Rate applied to the next priced round.
- Capital Flexibility: Operates under a single-instrument mechanism, deferring complex shareholder agreements.
- Governance Minimums: Investors usually waive immediate board representation and operational veto rights in exchange for conversion priority.
2. Structural Mapping: Term Sheet vs. iSAFE Note
| Structural Vector | Traditional Priced Equity (Term Sheet) | iSAFE Note (Pre-Equity Instrument) |
|---|---|---|
| Valuation Certainty | Fixed immediately. Requires a formal Valuation Report from a Registered Valuer under Section 56(2)(viib) of the Income Tax Act. | Deferred. Converts based on a Valuation Cap or Discount Rate applied to the next qualified pricing round. |
| Class of Security | Immediate allocation of Equity Shares or named Compulsorily Convertible Preference Shares (CCPS). | Issued as a unique class of unpriced CCPS that automatically converts into equity upon a triggering event. |
| Governance & Control | Expansive. Includes immediate Board seats, observer status, veto/affirmative voting rights, and right of first refusal. | Minimal. Investors waive board representation and voting blocks, gaining information rights and conversion protection. |
| Anti-Dilution Controls | Standard structural provisions (Full Ratchet or Broad-Based Weighted Average anti-dilution mechanisms). | Protected by the Valuation Cap. If subsequent rounds price lower, the cap guarantees a higher proportional equity share. |
| Secretarial Overhead | High. Requires immediate authorized capital expansion, filing Form SH-7, Form PAS-3, and holding an EGM. | Low at execution. Requires standard preference share placement filings, but avoids immediate capital expansion friction. |
| Transaction Costs | Substantial. Involves extensive legal due diligence, drafting long-form SSAs, SHAs, and revised Articles of Association (AoA). | Minimal. Uses standardized, pre-drafted template frameworks, reducing legal drafting hours and advisory costs. |
| Founder Autonomy | Diluted from day one. Board composition shifts and structural operational decisions require investor assent. | Preserved. Founders retain operational control and undivided board autonomy until a formal pricing round occurs. |
3. Corporate Secretarial and Legal Advisory Perspectives
The Procedural Hurdle of Valuations in India
Under Section 62(1)(c) of the Companies Act, 2013, read alongside Rule 13 of the Companies (Share Capital and Debentures) Rules, 2014, priced rounds require an immediate valuation report from a Registered Valuer. For seed-stage companies with unproven unit economics, locking in an artificial price can trigger pricing risks under Section 56(2)(viib) of the Income Tax Act if the premium is deemed unjustified. The iSAFE note circumvents this immediate risk by deferring valuation to a stage where mature commercial metrics are established.
Authorized Capital Sequencing
Priced rounds require an immediate expansion of the company's authorized share capital to accommodate the new issue, necessitating filings via MCA Form SH-7. Conversely, an iSAFE structure utilizes an unpriced preference allocation model. While the initial issue must fit within the existing preference capital limits, the formal expansion of equity capital is safely deferred until the conversion event occurs.
Conclusion
Neither instrument is universally superior; each serves a specific stage of corporate development. Term Sheets remain the standard framework for institutional Series A and onward rounds, where investors require robust corporate governance controls, clear anti-dilution boundaries, and immediate board oversight. For pre-seed, seed, and bridge capital rounds, the iSAFE note provides a highly efficient alternative. It allows founders to secure vital growth capital, defer complex valuation negotiations, and preserve operational speed without getting bogged down by legal overhead.
Disclaimer:
This document is provided by Chaudhary & Negi Partners solely for general informational purposes and does not constitute legal or professional advice. No professional-client relationship is created by virtue of this document, and it is not intended to solicit work or advertise the Firm's services. While due care has been taken in its preparation, the Firm does not warrant the accuracy or completeness of the information contained herein. Readers are advised to seek specific professional advice before acting upon any information contained herein. Laws and regulations are subject to change, and this document is the exclusive intellectual property of Chaudhary & Negi Partners and may not be reproduced or circulated without prior written consent.